You have 9 free searches left this month | for more free features.

Aripiprazole; Acute schizophrenia episode; positive symptoms

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Schizophrenia Episode Trial in China (Aripiprazole)

Completed
  • Acute Schizophrenia Episode
  • Hefei, Anhui, China
  • +11 more
Feb 3, 2021

Schizophrenia, Schizotypal Disorder, Delusional Disorder Trial in Munich (Metacognitive and Defusion Training)

Active, not recruiting
  • Schizophrenia
  • +12 more
  • Metacognitive and Defusion Training
  • Munich, Bavaria, Germany
    Max Planck Institute of Psychiatry
Aug 23, 2022

Schizophrenia, Schizoaffective Disorder, Schizotypal Disorder Trial in Worldwide (SUCCEED Community-Based Intervention)

Recruiting
  • Schizophrenia
  • +10 more
  • SUCCEED Community-Based Intervention
  • Blantyre, Southern, Malawi
  • +3 more
Aug 17, 2023

Resistant Schizophrenia From the Illness Onset

Not yet recruiting
  • Treatment-resistant Schizophrenia
  • risperidone, olanzapine, aripiprazole
  • (no location specified)
Nov 7, 2023

Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia Trial (Aripiprazole 10 MG)

Not yet recruiting
  • Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
  • Aripiprazole 10 MG
  • (no location specified)
Mar 10, 2023

Schizophrenia, Schizoaffective Disorder, Depressive Type, Schizophreniform Disorder Trial in Los Angeles (Aripiprazole Lauroxil,

Recruiting
  • Schizophrenia
  • +2 more
  • Aripiprazole Lauroxil
  • +2 more
  • Los Angeles, California
    University of California, Los Angeles
Aug 16, 2021

Schizophrenia Trial in Miami (Aripiprazole Lauroxil, Computerized cognitive and functional skills training)

Not yet recruiting
  • Schizophrenia
  • Aripiprazole Lauroxil
  • Computerized cognitive and functional skills training
  • Miami, Florida
    Jackson Memorial Hospital
Dec 14, 2022

Schizophrenia, Negative Symptoms in Schizophrenia Trial in Shanghai (Agomelatine)

Recruiting
  • Schizophrenia
  • Negative Symptoms in Schizophrenia
  • Shanghai, China
    Shanghai Mental Health Center
Dec 9, 2022

Schizophrenia, Myelin Degeneration, Cognition Disorder Trial in Milan (Aripiprazole)

Recruiting
  • Schizophrenia
  • +2 more
  • Milan, Italy
    Prof. Paolo Brambilla
Apr 14, 2022

Striatal Connectivity and Clinical Outcome in Psychosis

Recruiting
  • Psychotic Disorders
  • Risperidone or Aripiprazole (patients only)
  • Glen Oaks, New York
    Zucker Hillside Hospital
Jan 24, 2022

Schizophrenia and Related Disorders Trial in Douliu, Yunlin (Repetitive Transcranial Magnetic Stimulation)

Recruiting
  • Schizophrenia and Related Disorders
  • Repetitive Transcranial Magnetic Stimulation
  • Douliu, Yunlin, Taiwan
    Department of Psychiatry, National Taiwan University Hospital Yu
Jan 2, 2023

Negative Symptoms in Schizophrenia Trial (Metacognitive Training for Negative Symptoms (MCT), Supportive Counselling)

Not yet recruiting
  • Negative Symptoms in Schizophrenia
  • Metacognitive Training for Negative Symptoms (MCT)
  • Supportive Counselling
  • (no location specified)
Nov 6, 2023

Schizophrenia Trial in Xi'an (Brexpiprazole, Aripiprazole)

Completed
  • Schizophrenia
  • Xi'an, Shanxi, China
    No.15 Yanyin Road, Yanta District
Nov 11, 2021

Schizophrenia Trial in Worldwide (MK-8189, Risperidone, Placebo to MK-8189)

Recruiting
  • Schizophrenia
  • Bentonville, Arkansas
  • +92 more
Jan 5, 2023

Schizophrenia Trial in Changsha (transcranial magnetic stimulation, sham stimulation)

Active, not recruiting
  • Schizophrenia
  • transcranial magnetic stimulation
  • sham stimulation
  • Changsha, Hunan, China
    Central South University
Nov 16, 2022

Schizophrenia Trial in Atlanta (Infliximab, Placebo)

Not yet recruiting
  • Schizophrenia
  • Atlanta, Georgia
  • +1 more
Apr 10, 2023

Schizophrenia Trial in Seoul (WID-RGC20(Cariprazine) 3mg/day, WID-RGC20(Cariprazine) 6mg/day, Placebo for WID-RGC20(Cariprazine)

Enrolling by invitation
  • Schizophrenia
  • WID-RGC20(Cariprazine) 3mg/day
  • +2 more
  • Seoul, Korea, Republic of
    Whan In Pharm.
Dec 8, 2021

Schizophrenia, Schizophrenia; Psychosis Trial in Ukraine, United States (Xanomeline and Trospium Chloride Capsules, Placebo)

Recruiting
  • Schizophrenia
  • Schizophrenia; Psychosis
  • Xanomeline and Trospium Chloride Capsules
  • Placebo
  • Bentonville, Arkansas
  • +28 more
Aug 12, 2022

Social Phobia, Psychosis Trial in Verdun (Manualized group Cognitive-behavioral therapy (CBT) for social anxiety in first

Completed
  • Social Phobia
  • Psychosis
  • Manualized group Cognitive-behavioral therapy (CBT) for social anxiety in first episode psychosis
  • Group Computer assisted cognitive remediation therapy
  • Verdun, Quebec, Canada
    Douglas Mental Health University Institute
Oct 21, 2022

Neurophysiologic Biomarkers for Cognitive Rehabilitation

Not yet recruiting
  • Schizophrenia Spectrum Disorders
  • Neurophysiologic Biomarker Assessments
  • San Diego, California
    VA San Diego Healthcare System, San Diego, CA
Jul 6, 2023

Breakthrough Symptoms With Long-Acting Injectable Medications

Not yet recruiting
  • Schizophrenia
  • Schizophrenia Relapse
  • Second Generation Long-Acting Injectable Antipsychotic Medications
  • (no location specified)
Jul 22, 2022

Schizophrenia Trial in Copenhagen (Aripiprazole)

Completed
  • Schizophrenia
  • Copenhagen, Glostrup, Denmark
    Center for Neuropsychiatric Schizophrenia Research, University o
Apr 27, 2021

Schizophrenia, Schizoaffective Disorder Trial in Worldwide (RO6889450, Placebo, Risperidone)

Terminated
  • Schizophrenia, Schizoaffective Disorder
  • Little Rock, Arkansas
  • +49 more
Jul 14, 2022

Psychosis, Schizophrenia Trial in Zürich (Motivational Interviewing, Supportive conversations)

Recruiting
  • Psychosis
  • Schizophrenia
  • Motivational Interviewing
  • Supportive conversations
  • Zürich, Switzerland
    Psychiatric University Hospital Zurich
Jun 9, 2023